» Articles » PMID: 9721861

Identification of a Novel Metastasis-suppressor Region on Human Chromosome 12

Overview
Journal Cancer Res
Specialty Oncology
Date 1998 Aug 29
PMID 9721861
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

There is a critical need for markers that can be used to predict accurately the malignant potential of histological prostate cancers (J. T. Isaacs. Am. J. Pathol., 150: 1511-1521, 1997). Metastasis-suppressor genes are attractive candidates for marker development because, by definition, their loss should be associated with the acquisition of metastatic ability. In an effort to identify such genes, a single copy of human chromosome 12, tagged with the neomycin resistance gene, was introduced into highly metastatic Dunning AT6.1 prostate cancer cells by microcell-mediated chromosomal transfer. Thirty-two AT6.1-12 clonal cell lines were established and the region(s) of chromosome 12 retained was determined by sequence tagged site-based PCR analysis. Representative AT6.1-12 clones containing overlapping regions of chromosome 12 were characterized cytogenetically and were shown to have a normal complement of parental AT6.1 rat chromosomes. Fluorescence in situ hybridization, performed on representative AT6.1-12 hybrids, demonstrated a single human chromosome 12-specific signal. The metastatic ability of six representative clones was tested in immunodeficient mice. All of the AT6.1-12 clones showed the same in vivo growth rates as the control AT6.1-neo cells. Clonal cell lines that contained a conserved approximately 70-cM portion of chromosome 12 (e.g., AT6.1-12-8, -8-1, and -8-3), showed a >30-fold suppression in the number of macroscopic surface lung metastases. Mice that received injections of these cells developed a mean number 4 lung metastases whereas mice that received injections of other AT6.1-12 hybrids (lacking the approximately 70-cM region) or AT6.1-neo control cells, developed a mean number of 140 metastases. Interestingly, histological examination of the lungs of the mice that received injections of AT6.1-12-8 cells showed essentially no microscopic metastases. These findings suggest that a gene(s) encoded by the approximately 70-cM portion of human chromosome 12 suppresses an early step in the metastatic cascade.

Citing Articles

IGFBP5 domains exert distinct inhibitory effects on the tumorigenicity and metastasis of human osteosarcoma.

Luther G, Lamplot J, Chen X, Rames R, Wagner E, Liu X Cancer Lett. 2013; 336(1):222-30.

PMID: 23665505 PMC: 3704951. DOI: 10.1016/j.canlet.2013.05.002.


Metastasis suppressor genes.

Yan J, Yang Q, Huang Q Histol Histopathol. 2013; 28(3):285-92.

PMID: 23348381 PMC: 3910084. DOI: 10.14670/HH-28.285.


Genomics screens for metastasis genes.

Yan J, Huang Q Cancer Metastasis Rev. 2012; 31(3-4):419-28.

PMID: 22684367 PMC: 4071451. DOI: 10.1007/s10555-012-9362-z.


Targeted detection of in vivo endogenous DNA base damage reveals preferential base excision repair in the transcribed strand.

Reis A, Mills W, Ramachandran I, Friedberg E, Thompson D, Queimado L Nucleic Acids Res. 2011; 40(1):206-19.

PMID: 21911361 PMC: 3245927. DOI: 10.1093/nar/gkr704.


Suppressive roles of calreticulin in prostate cancer growth and metastasis.

Alur M, Nguyen M, Eggener S, Jiang F, Dadras S, Stern J Am J Pathol. 2009; 175(2):882-90.

PMID: 19608864 PMC: 2716982. DOI: 10.2353/ajpath.2009.080417.